About Ospedale Garibaldi-Nesima
Clinical Trials at Ospedale Garibaldi-Nesima
During the past decade, Ospedale Garibaldi-Nesima conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ospedale Garibaldi-Nesima" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 2 trials, followed by "Gruppo di Ricerca GISSI" with 2 trials
sponsored, "Coloplast A/S" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Heart Care Foundation"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Garibaldi-Nesima"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Ospedale Garibaldi-Nesima
According to Clinical.Site data, the most researched conditions in "Ospedale Garibaldi-Nesima" are
"Atrial Fibrillation" (1 trials), "Diffuse Large B Cell Lymphoma (DLBCL)" (1 trials), "Elderly Patients (>65 Years)" (1 trials), "Follicular Lymphoma" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Ospedale Garibaldi-Nesima" in a lesser frequency.
Clinical Trials Intervention Types at Ospedale Garibaldi-Nesima
Most popular intervention types in "Ospedale Garibaldi-Nesima" are "Drug" (8 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Altis Single Incision Sling System" (1 trials), "Cabozantinib" (1 trials), "Catapresan TTS 2" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ospedale Garibaldi-Nesima
The vast majority of trials in "Ospedale Garibaldi-Nesima" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Ospedale Garibaldi-Nesima
Currently, there are NaN active trials in "Ospedale Garibaldi-Nesima".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Ospedale Garibaldi-Nesima,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ospedale Garibaldi-Nesima, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".